摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (2S,5R)-trans-2-methyl-1,3-oxathiolane-5-carboxylate | 103066-67-7

中文名称
——
中文别名
——
英文名称
methyl (2S,5R)-trans-2-methyl-1,3-oxathiolane-5-carboxylate
英文别名
methyl (2S,5R)-2-methyl-1,3-oxathiolane-5-carboxylate
methyl (2S,5R)-trans-2-methyl-1,3-oxathiolane-5-carboxylate化学式
CAS
103066-67-7
化学式
C6H10O3S
mdl
——
分子量
162.21
InChiKey
OZKHMOLYVGGOPV-WHFBIAKZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    60.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Molecular requirements of the recognition site of cholinergic receptors. 22. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide
    摘要:
    The potent cholinergic agonist (+/-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide (+/-)-1] was resolved into enantiomeric forms. Their absolute configurations were established by a synthetic pathway that also allowed the synthesis of the corresponding diastereomeric (+)- and (-)-trans-2-methyl-5-[(dimethylamino)-methyl]-1,3-oxathiolane methiodide [(+)- and (-)-10]. Compound (+)-1, which is the most potent of the four isomers, showed the same absolute configuration as L-(+)-muscarine and (+)-cis-dioxolane. The four isomers were tested on guinea pig ileum and frog rectus abdominis, and their muscarinic and nicotinic potency (EPMR) and selectivity were determined. The relationships between stereoisomerism and potency are discussed.
    DOI:
    10.1021/jm00159a009
  • 作为产物:
    参考文献:
    名称:
    TEODORI E.; GUALTIERI F.; ANGELI P.; BRASILI L.; GIANNELLA M.; PIGINI M., J. MED. CHEM., 29,(1986) N 9, 1610-1615
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • TEODORI E.; GUALTIERI F.; ANGELI P.; BRASILI L.; GIANNELLA M.; PIGINI M., J. MED. CHEM., 29,(1986) N 9, 1610-1615
    作者:TEODORI E.、 GUALTIERI F.、 ANGELI P.、 BRASILI L.、 GIANNELLA M.、 PIGINI M.
    DOI:——
    日期:——
  • Molecular requirements of the recognition site of cholinergic receptors. 22. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide
    作者:Elisabetta Teodori、Fulvio Gualtieri、Piero Angeli、Livio Brasili、Mario Giannella、Maria Pigini
    DOI:10.1021/jm00159a009
    日期:1986.9
    The potent cholinergic agonist (+/-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide (+/-)-1] was resolved into enantiomeric forms. Their absolute configurations were established by a synthetic pathway that also allowed the synthesis of the corresponding diastereomeric (+)- and (-)-trans-2-methyl-5-[(dimethylamino)-methyl]-1,3-oxathiolane methiodide [(+)- and (-)-10]. Compound (+)-1, which is the most potent of the four isomers, showed the same absolute configuration as L-(+)-muscarine and (+)-cis-dioxolane. The four isomers were tested on guinea pig ileum and frog rectus abdominis, and their muscarinic and nicotinic potency (EPMR) and selectivity were determined. The relationships between stereoisomerism and potency are discussed.
查看更多

同类化合物

顺式-1,3-氧硫杂环戊烷-4-酮O-((甲基氨基)羰基)肟 甲基1,3-恶噻戊环-2-羧酸酯 反-2-顺式-4,5-三甲基-1,3-恶噻戊环 三甲基-[[(2S,5S)-2-甲基-3-氧代-1,3-氧硫杂环戊烷-5-基]甲基]铵碘化物 三甲基-[(2-甲基-1,3-氧硫杂环戊烷-5-基)甲基]铵 beta-磺基丙酸酐 5-羟基-1,3-噁硫杂烷-2-羧酸 5-甲基恶噻戊环2,2-二氧化物 5-(氯甲基)-1,3-恶噻戊环-2-硫酮 5-(异丁烯酰氧基)甲基-1,3-氧硫杂环戊烷-2-硫酮 4-甲基-1,2-噁噻戊环2,2-二氧化 4-溴-[1,2]噁硫烷2,2-二氧化物 4,5-二甲基-2-[2-(甲硫基)乙基]-1,3-恶噻戊环 3-苄基-1,2-氧硫杂环戊烷2,2-二氧化物 3-氟-1,3-丙烷磺酸内酯 3-十三烷基-1,3-丙烷磺内酯 2-甲基-5-三甲基铵甲基-1,3-恶噻戊环 2-甲基-1,3-恶噻戊环 2-异丙基-1,3-恶噻戊环 2-亚氨基-1,3-恶噻戊环-4-羧酸 2-(2,6-二甲基-1,5-庚二烯-1-基)-1,3-恶噻戊环 2,4-丁磺内酯 2,4,4,5,5-五氟-2-(三氟甲基)-1,3-恶噻戊环3,3-二氧化物 1-巯基十四烷-3-醇 1-[(2Z)-1,3-氧硫杂环戊烷-2-亚基]脲 1-(1,3-氧硫杂环戊烷-2-基)乙酮 1,3-氧硫杂环戊烷-5-酮 1,3-氧硫杂环戊烷-2-酮 1,3-恶噻戊环 1,3-丙烷磺内酯 (Z)-5-丙基-1,3-氧硫杂环戊烷-4-酮O-((甲基氨基)羰基)肟 3,4-dimethyl-1,2-oxathiolane-5-one-2,2-dioxide 5,5-dimethyl-1,3-oxathiolan-2-one 2-(5-methyl-furan-2-yl)-[1,3]oxathiolane 5,5-dimethyl-4-(2-yne butylidene)-2-thione-1,3-oxathiolane N-(1-adamantyl)-1,3-oxathiolan-2-imine 5-ethyl-1,3-oxathiolane-2-thione 2,2,4,4,5,5-hexafluoro[1,3]oxathiolane-3,3-dioxide 4,4,5,5-tetramethyl-1,3-oxathiolane-2-thione 3-phenyl-3a,6a-dihydro-6H-[1,2]oxathiolo[3,4-d]isoxazole 4,4-dioxide 2-[1-methylbutenyl]-1,3-oxathiolane 2-trifluoromethyl-1,3-oxathiolan-5-one 2-butylidene-5-methyl-1,3-oxathiolane N-(tert-butyl)-5-methyl-1,3-oxathiolan-2-imine 5-(allyloxymethyl)-1,3-oxathiolane hexahydrobenzo[d][1,3]oxathiole 5-ethyl-1,3-oxathiolane (+/-)-5,6-dimethyl-3a,4,7,7a-tetrahydro-2,1-oxathiaindene 1,1-dioxide 2-(thiophen-2-yl)-1,3-oxathiolane 2-Undecyl-1,3-oxathiolane